SPECIAL FEATURE - Prefilled Syringes & PCM: Biologics Present a New Set of Challenges

Paul Sullivan provides insights on the future of the prefilled syringe market

Special Feature begins on page 39.

The demand for prefilled syringes continues to grow as more patients are being required to self-administer medications, such as the increasing number of biologics and biosimilars entering the market. As these products continue to augment and launch into new therapeutic sectors, training and education will remain a critical success factor that will determine a patient’s ability to safely and effectively use prefilled syringes and adhere to therapy, explains Paul Sullivan, Associate Director of Business Development at Noble.

View Full Story >

Posted by